Close Menu
    What's Hot

    The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

    August 13, 2026

    US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

    August 13, 2026

    Editor’s Letter – Volume 2, Issue 8, August 2026

    August 12, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Lincoln Financial Reinsures Universal Life Block With Talcott

      August 3, 2026

      US Annuity Sales Set New Quarterly Record in Second Quarter

      August 3, 2026

      Big Year of Growth for Life/Annuity Sidecar-Like Activity in 2025

      July 2, 2026

      Sixth Street To Become Majority Shareholder of Monument Re

      June 30, 2026

      US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

      August 13, 2026

      Shaping the Future of Health Insurance Through Innovation and Analytics

      June 10, 2026

      Q&A: Dr Christoph Schmitt, Director, Insurance, Fitch Ratings

      May 28, 2026

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      US Life Carriers Eyeing VM-22 for a Pension Risk Transfer Pricing Advantage in 2027

      August 12, 2026

      Elementis Group Pension Scheme Completes Bulk Purchase Annuity Buy-In With Aviva

      August 5, 2026

      Hickson UK Group Pension Scheme Completes Bulk Purchase Annuity Transaction With Royal London

      August 3, 2026

      UK Insurance Company Pension Scheme Completes Bulk Purchase Annuity Transaction With M&G

      August 3, 2026

      Record Low Mortality Rates So Far in England and Wales in 2026

      July 9, 2026

      Organ Transplant Improvements Test Life Expectancy Assessment Models

      July 8, 2026

      The Pursuit of Everlasting Life Unlikely to Shift Actuarial Models

      June 10, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026

      The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

      August 13, 2026

      New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

      August 12, 2026

      The Crucial Role of Regular Medical Record Reviews in Life Settlement Investments

      August 12, 2026

      Corry Capital Advisors Adds John Daniel as Senior Director of Analytics and AI Strategy

      August 6, 2026

      The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

      August 13, 2026

      US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

      August 13, 2026

      Editor’s Letter – Volume 2, Issue 8, August 2026

      August 12, 2026

      New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

      August 12, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 8, August 2026

      August 12, 2026

      Editor’s Letter – Volume 2, Issue 7, July 2026

      July 8, 2026

      Editor’s Letter – Volume 2, Issue 6, June 2026

      June 10, 2026

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    Q&A: Rob Haynie, Life Insurance Settlements

    Secondary Life Markets November 9, 2023By Greg Winterton
    Life Risk News Q&A
    Share
    Twitter LinkedIn Email

    A recent report published by asset manager Conning suggests that the life settlement industry is poised for continued growth in the coming years. Life Risk News’ Greg Winterton spoke to Rob Haynie, Managing Director at life settlements broker Life Insurance Settlements, Inc, to get his views on how the life settlement market has done in 2023 and what his expectations are for 2024. 

    GW: Rob, let’s start with 2023. At the end of last year, you told Life Risk News that you expected the main reasons why seniors look to sell their policies to be covering medical bills and simply not needing the policy anymore. Has that forecast proven correct? What about the cost of living crisis? 

    RH: Yes, the two main reasons you mention are the primary drivers of policy sales. It’s important to remember that the policies transacted in the intermediated market tend to carry a higher face value than the direct to consumer channel. The policies we bring to market tend to be associated with a wealthier socioeconomic group so while the cost of living crisis has contributed a little bit to deal flow, it’s not been a significant driver. Medical bills can get very expensive in the United States, and at the age cohorts we tend to work with, it’s frequently the case that the policy is no longer needed. I think those two reasons will remain the top two reasons why policies come to market because they’re not cyclical. 

    GW: Moving onto deal flow more generally. Again, last year, you said that you’d expect 2022 to end up higher than 2021. You were right. What’s your observation this year? 

    RH: Speaking for ourselves, we’ve seen increased activity in terms of the various different advisor groups coming to us looking to sell their client’s policy. Anecdotally, from conversations I’ve had with peers and clients, I’d say the industry should show growth again when the numbers for 2023 come out in late spring or early summer next year. How much growth though is hard to predict. 

    GW: Are you concerned that the increasing influence of the direct to consumer channel in the secondary market might take deal flow away from the intermediated market? 

    RH: No. Actually, DTC helps those of us in the intermediated market in terms of awareness. Remember that both the individual insured senior and their advisers are seeing TV commercials. Yes, that naturally leads to increased deal flow for the direct to consumer life settlement providers. But equally, many of the folks that are seeing these advertisements are then using that as a nudge to go away and do their own research. Often, that research includes contacting a trusted adviser like a life insurance agent, lawyer, or accountant, which then brings them to firms like ours. And the flip side is that those advisors proactively contact their clients to talk about life settlements. DTC is good for our industry overall. 

    GW: Changing gears a little bit. In the summer, you published a short podcast series. What was the driver of that decision? Will you do any more? 

    RH: Those who know me know that I’ve been beating the drum about awareness in the life settlement market for years. The podcast was – is – designed to be additive to the conversation. Lapse rates are still way, way too high. Not nearly enough life insurance policyowners understand the nuances of the life settlement market, and even more aren’t even aware that the life settlement option even exists. The more content out there that people might stumble upon, the merrier, in my view. And we might do some more. We will continue the podcast with 10 more episodes beginning in a few weeks. Our plan is to feature some of the best and brightest in the life settlement industry and get their unique perspectives and help educate the listener on the entirety of our marketplace and illuminate the value it brings to consumers. 

    GW: Lastly, Rob, looking ahead to 2024. Are there any hurdles on the road to growth that the life settlement market might have to negotiate next year?  

    RH: I think the main thing is the uncertainty around the macroeconomic environment. It’s difficult to tell whether we’re at the top of the current rising interest regime or not. Higher rates impact the ability of asset managers in the market to raise capital because of the relatively higher appeal of bonds, but that’s something out of their control. I prefer to focus on what we can control, which is to continue to work hard and keep educating the consumer and their advisors. There is a lot that we as an industry can do, regardless of the economic and social environment. 

    2023 - November Life Settlements Longevity Risk Q&A Volume 2 Issue 11 - November 2023
    Share. Twitter LinkedIn Email

    Related Posts

    The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

    August 13, 2026By LMI Newsdesk

    New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

    August 12, 2026By Greg Winterton

    The Crucial Role of Regular Medical Record Reviews in Life Settlement Investments

    August 12, 2026By Fergus Bescoby

    Corry Capital Advisors Adds John Daniel as Senior Director of Analytics and AI Strategy

    August 6, 2026By LMI Newsdesk
    Latest Issue

    New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

    August 12, 2026

    The Crucial Role of Regular Medical Record Reviews in Life Settlement Investments

    August 12, 2026

    US Life Carriers Eyeing VM-22 for a Pension Risk Transfer Pricing Advantage in 2027

    August 12, 2026

    End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

    July 22, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.